{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/348320636"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Network collaborations with these other HIV vaccine groups may be of great importance in addressing critical challenges in vaccine research and development, such as identifying, recruiting, and retaining the highest risk populations, implementing advanced product development and manufacturing, developing the necessary facilities and infrastructure for clinical trials, and training a larger cadre o" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "nih.gov" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/130781270"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/348320636"] } } }
